IBB: Growth And Innovation

Jun. 28, 2021 1:22 AM ETiShares Biotechnology ETF (IBB)XBI, IBB9 Comments

Summary

  • We are long-term bullish on the biotech and pharmaceutical sector.
  • The iShares Biotechnology ETF offers a great choice for exposure to the leading biotech and pharmaceutical companies with low cost, diversification, tradability, and liquidity.
  • This article performs a comparative analysis of IBB against its closest competitor and the overall market in terms of growth, inflation, volatility to further examine its pros and cons.

Green DNA
Andriy Onufriyenko/Moment via Getty Images

Thesis

Our family are long-term bulls on the biotech and pharmaceutical sector. To us, it's the most innovative sector for the future aided by the most reliable secular trend - people's desire to live longer and heathier. The iShares Biotechnology

This article was written by

9.82K Followers

Sensor Unlimited is an economist by training with a PhD, with a focus on financial economics. She is a quantitative modeler and for the past decade she has been covering the mortgage market, commercial market, and the banking industry. She writes about asset allocation and ETFs, particularly those related to the overall market, bonds, banking and financial sectors, and housing markets.

Sensor Unlimited contributes to the investing group Envision Early Retirement which is led by Sensor Unlimited. They offer proven solutions to generate both high income and high growth with isolated risks through dynamic asset allocation. Features include: two model portfolios - one for short-term survival/withdrawal and one for aggressive long-term growth, direct access via chat to discuss ideas, monthly updates on all holdings, tax discussions, and ticker critiques by request. Learn More.

Analyst’s Disclosure:I am/we are long XBI. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About IBB ETF

SymbolLast Price% Chg
Expense Ratio
Div Frequency
Div Rate
Yield
Assets (AUM)
Compare to Peers

More on IBB

Related Stocks

SymbolLast Price% Chg
IBB
--